INVN

$20.25

Fund Essentials - as of Oct 31, 2025

Net Assets
$15M
Expense Ratio
0.55%
Dividend Yield (Current)
-
Holdings
51
Inception Date
Jan 6, 2025
Fund Family
Alger
Investment Style
••••••••••
Asset Class
••••••••••
Legal Structure
••••••••••
Dividend Frequency
NA

Performance

YTD-0.07%
1 Year-0.03%
3 Year+0.00%
5 Year+0.00%
10 Year+0.00%

Asset Allocation

Stocks: 97.13%
Cash: 2.87%

Price Chart (6M)

View Full Chart →

Top Holdings

View All →
TickerNameWeight
REGNRegeneron Pharmaceuticals, Inc.2.65%
JAZZJazz Pharmaceuticals Plc2.65%
TDCTeradata Corporation2.60%
ILMNIllumina, Inc.2.55%
BIIBBiogen Idec Inc.2.45%
Top 10 Concentration: 24.65%Report Date: Oct 31, 2025

Peer Comparison

Benchmark
••••••••••
Outperforming by ••••%
Ranked #••• of •,••• funds
This ETF
+••.••%
Peer Avg
+••.••%
Premium Feature
Sign in to unlock peer comparison, category rankings and more
1 Month
-6.61%
YTD
-3.20%
1 Year
-3.20%
3 Year
+0.06%

Top 10 Holdings (24.6% of portfolio)

#TickerNameSectorWeight
1REGNRegeneron Pharmaceuticals, Inc.Health Care2.65%
2JAZZJazz Pharmaceuticals PlcHealth Care2.65%
3TDCTeradata CorporationUnknown2.60%
4ILMNIllumina, Inc.Health Care2.55%
5BIIBBiogen Idec Inc.Health Care2.45%
6UTHRUTD THERAPEUTHealth Care2.40%
7EAElectronic Arts, Inc.Communication Services2.36%
8PATHUipath Inc Class AInformation Technology2.36%
9INCYIncyteHealth Care2.32%
10LYFTLyft Inc. Class AConsumer Discretionary2.31%